Drugs/Recall·openFDA/drug

Oasis Medical, Inc. — Class II: Oasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile, Ma

MediumPublished May 20, 2026· AI-analyzed May 25, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Oasis Medical, Inc. has initiated a Class II recall for Oasis Tears PF, Preservative-Free Lubricant Eye Drops, due to a lack of assurance of sterility following FDA inspection observations at the manufacturing facility, Excelvision.

Who it affects

This recall affects Oasis Medical, Inc., their contract manufacturer Excelvision, and healthcare providers or distributors managing NDC 42126-6400-1.

Why it matters

A Class II recall for sterility concerns in preservative-free ophthalmic products is a significant compliance event, as these products lack antimicrobial agents to mitigate contamination risks. The source indicates the action originated from facility-level inspectional findings rather than confirmed product contamination, suggesting that regulatory scrutiny of sterile fill-finish operations at CMOs remains a high priority for the FDA.

Practical takeaway

Affected firms should immediately verify inventory against the specified NDC, quarantine impacted lots, and evaluate the sterility assurance profiles of third-party manufacturers, particularly for preservative-free ophthalmic products.

FDA source material

Class II. Reason: Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision.. Product: Oasis Tears PF, Preservative-Free Lubricant Eye Drops, 10mL/0.34 Fl OZ Bottle, Sterile, Manufactured for: OASIS Medical, Inc., 514 S. Vermont Ave., Glendora, CA 91741, USA, Made in France, NDC 42126-6400-1.. Firm: Oasis Medical, Inc. (Glendora CA United States). Status: Ongoing.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.